We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Adel - Cost Analysis of Using Plerixafor Plus G-CSF Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma Patients Treated At Memorial Sloan-Kettering Cancer Center (MSKCC)
Nelly G. Adel, PharmD, BCOP, BCPS
Memorial Sloan-Kettering Cancer Center
New York, New York, USA
12.01.11

Be the first to comment

 related articles